These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35040137)

  • 21. Bone densitometry in pediatric patients treated with pamidronate.
    Grissom LE; Kecskemethy HH; Bachrach SJ; McKay C; Harcke HT
    Pediatr Radiol; 2005 May; 35(5):511-7. PubMed ID: 15655696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adequate treatment with bisphosphonates for senile osteoporosis].
    Takada J; Imoto K; Iba K; Yamashita T
    Nihon Rinsho; 2006 Sep; 64(9):1657-61. PubMed ID: 16972675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of bisphosphonates in pediatrics.
    Baroncelli GI; Bertelloni S
    Horm Res Paediatr; 2014; 82(5):290-302. PubMed ID: 25376487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of bisphosphonates for osteoporosis or osteopenia in Crohn's disease: a meta-analysis.
    Guo Z; Wu R; Gong J; Zhu W; Li Y; Li N; Li J
    Dig Dis Sci; 2013 Apr; 58(4):915-22. PubMed ID: 23179146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS).
    Sanders J; Crawford B; Gibson J; Joy Ho P; Iland H; Joshua D
    Int J Lab Hematol; 2007 Oct; 29(5):395-7. PubMed ID: 17824924
    [No Abstract]   [Full Text] [Related]  

  • 26. Fractures in children with cerebral palsy.
    Mughal MZ
    Curr Osteoporos Rep; 2014 Sep; 12(3):313-8. PubMed ID: 24964775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Bisphosphonates for Osteoporosis or Osteopenia in Cardiac Transplant Patients: A Meta-Analysis.
    Zhao J; Wang C; Hu Z
    Transplant Proc; 2015 Dec; 47(10):2957-64. PubMed ID: 26707321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evolving role of bisphosphonates: cancer treatment-induced bone loss.
    Mundy GR
    Oncology (Williston Park); 2004 May; 18(5 Suppl 3):9-10. PubMed ID: 15202581
    [No Abstract]   [Full Text] [Related]  

  • 29. Bisphosphonates in the management of thalassemia-associated osteoporosis: a systematic review of randomised controlled trials.
    Giusti A
    J Bone Miner Metab; 2014 Nov; 32(6):606-15. PubMed ID: 24748165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone: Use of bisphosphonates in children-proceed with caution.
    Marini JC
    Nat Rev Endocrinol; 2009 May; 5(5):241-3. PubMed ID: 19444252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonates in the treatment of thalassemia-associated osteoporosis.
    Gaudio A; Morabito N; Xourafa A; Macrì I; Meo A; Morgante S; Trifiletti A; Lasco A; Frisina N
    J Endocrinol Invest; 2008 Feb; 31(2):181-4. PubMed ID: 18362512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bisphosphonates. A neu therapy principle in calcium and bone metabolism disorders].
    Raue F
    Internist (Berl); 1999 Apr; 40(4):448-55. PubMed ID: 10354947
    [No Abstract]   [Full Text] [Related]  

  • 33. Annual Injection of Zoledronic Acid Improves Bone Status in Children with Cerebral Palsy and Rett Syndrome.
    Wiedemann A; Renard E; Hernandez M; Dousset B; Brezin F; Lambert L; Weryha G; Feillet F
    Calcif Tissue Int; 2019 Apr; 104(4):355-363. PubMed ID: 30554334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using pamidronate for osteoporosis.
    Di Leo G; Neri E; Ventura A
    J Pediatr; 2004 May; 144(5):689-90. PubMed ID: 15151127
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bisphosphonates in osteoporosis therapy. Standards and perspectives].
    Reinsdorf S; Habermann B; Hochmuth K; Kurth AA
    Orthopade; 2007 Feb; 36(2):110-7. PubMed ID: 17252258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bisphosphonates: expanded roles in the treatment of patients with cancer.
    Viale PH; Sanchez Yamamoto D
    Clin J Oncol Nurs; 2003; 7(4):393-401. PubMed ID: 12929272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonates in the prevention and treatment of bone metastases.
    Ramaswamy B; Shapiro CL
    Oncology (Williston Park); 2003 Sep; 17(9):1261-70; discussion 1270-2, 1277-8, 1280. PubMed ID: 14569853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisphosphonate use in children with pediatric osteoporosis and other bone conditions.
    Szalay EA
    J Pediatr Rehabil Med; 2014; 7(2):125-32. PubMed ID: 25096864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bisphosphonates for osseus invasion caused by bronchial carcinoma].
    Bartl R
    Dtsch Med Wochenschr; 2008 Nov; 133(48):2530. PubMed ID: 19021088
    [No Abstract]   [Full Text] [Related]  

  • 40. Current and future treatments of secondary osteoporosis.
    Soriano R; Herrera S; Nogués X; Diez-Perez A
    Best Pract Res Clin Endocrinol Metab; 2014 Dec; 28(6):885-94. PubMed ID: 25432359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.